Ho Teresa T, Gift Maja, Alexander Earnest
Department of Pharmacotherapeutics & Clinical Research, University of South Florida Taneja College of Pharmacy, Tampa, FL 33612, USA.
Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, FL 33612, USA.
Per Med. 2022 Jan;19(1):15-23. doi: 10.2217/pme-2021-0061. Epub 2021 Dec 9.
Characterize current perceptions, practices, preferences and barriers to integrating pharmacogenomics into patient care at an institution with an established pharmacogenomics clinic. A 16-item anonymous survey was sent to healthcare professionals practicing at Tampa General Hospital and the University of South Florida Health. Survey participants consisted of nine advanced practice providers, 41 pharmacists and 64 physicians. Majority of survey participants did not feel confident in their ability to interpret and apply pharmacogenomic results. In the past 12 months, 27% of physicians reported ordering a pharmacogenomic test. The greatest reported barrier to integrating pharmacogenomics was the absence of established guidelines or protocols. Most clinicians believed pharmacogenomics would be useful in their clinical practice but do not feel prepared to interpret pharmacogenomic results.
在一家设有成熟药物基因组学诊所的机构中,描述当前将药物基因组学整合到患者护理中的认知、实践、偏好和障碍。向坦帕综合医院和南佛罗里达大学健康中心执业的医疗保健专业人员发送了一份包含16项内容的匿名调查问卷。调查参与者包括9名高级执业提供者、41名药剂师和64名医生。大多数调查参与者对自己解读和应用药物基因组学结果的能力缺乏信心。在过去12个月中,27%的医生报告曾开具药物基因组学检测。报告中整合药物基因组学的最大障碍是缺乏既定的指南或方案。大多数临床医生认为药物基因组学在他们的临床实践中会有用,但觉得没有准备好解读药物基因组学结果。